PDF herunterladen
CC BY 4.0 · Neuropediatrics 2025; 56(02): 133-141
DOI: 10.1055/a-2516-9103
Short Communication

Newborn with Refractory Seizures due to Hemimegalencephaly and Tuberous Sclerosis Complex: Case Report and Literature Review

Mathies Rondagh 
1   Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands
,
Linda S. de Vries
1   Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands
,
Lotte E. van der Meeren
2   Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
3   Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands
,
Selma C. Tromp
4   Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands
,
Cacha M.P.C.D. Peeters-Scholte
4   Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands
,
Menno J.P. Toirkens
5   Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
,
Sylke J. Steggerda
1   Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands
› Institutsangaben Funding European Society for Paediatric Research (ESPR). Leids Universitair Fonds (LUF) and the Gratama Stichting, 2023-10/W233029-2-GSL. Strong Babies, SB-JO-2023-15. Honours College Leids Universitair Medisch Centrum, 240426. Janivo Stichting. Gisela Thier Fonds. Raynor Foundation. Vaillant Stichting
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Hemimegalencephaly (HME) is a rare congenital disorder that is initiated during embryonic development with abnormal growth of one hemisphere. Tuberous sclerosis complex (TSC), a genetic disorder, is rarely associated with HME.

We present a case of a newborn with HME with a confirmed mutation in the TSC-1 gene and describe the clinical course, findings on amplitude-integrated electroencephalography (aEEG), cranial ultrasound (CUS), MRI, and the postmortem evaluation. Furthermore, we conducted a comprehensive literature review of all reported newborns with HME and a genetically confirmed TSC mutation.

This infant experienced therapy-resistant seizures after birth despite treatment with multiple antiseizure medications. CUS and MRI revealed HME of the left hemisphere. Early functional hemispherectomy, around the age of 3 months, was considered but dismissed after multidisciplinary evaluation, medical ethical consultation, and multiple discussions with the parents. Care was redirected due to worsening clinical and neurologic conditions, increasing respiratory insufficiency, and ongoing therapy-resistant seizures. Postmortem evaluation of the brain revealed hamartomatous brain changes and irregular gyration of the enlarged hemisphere. in addition, these changes were also present in the previously considered unaffected side, raising thoughts about the potential effectiveness of functional hemispherectomy.

This case report illustrates that in cases with TSC abnormalities might not be confined solely to the initially considered affected side. This can have important therapeutic implications.

Keywords

hemimegalencephaly - neonatal seizures - tuberous sclerosis complex - postmortem - neuroimaging

Authors' Contributions

M.R. conceptualized and designed the study, collected data, drafted the initial manuscript, and critically reviewed and revised the manuscript.


S.J.S. and L.S.d.V. conceptualized and designed the study and critically reviewed and revised the manuscript.


L.E.v.d.M., S.C.T., C.M.P.C.D.P-S., and J.P.T. critically reviewed and revised the manuscript.


All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work.


Informed Consent

The parents provided informed consent and signed a consent form for publication regarding the medical condition of their infant.


Supplementary Material



Publikationsverlauf

Eingereicht: 24. September 2024

Angenommen: 10. Januar 2025

Accepted Manuscript online:
15. Januar 2025

Artikel online veröffentlicht:
28. Januar 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Di Rocco C, Battaglia D, Pietrini D, Piastra M, Massimi L. Hemimegalencephaly: clinical implications and surgical treatment. Childs Nerv Syst 2006; 22 (08) 852-866
    CrossrefPubMedSuche in Google Scholar
  • 2 Shim S, Shin JE, Lee SM. et al. A patient with tuberous sclerosis with hemimegalencephaly presenting with intractable epilepsy in the early neonatal period: a case report. Perinatology. 2022; 33 (04) 201-207
    CrossrefPubMedSuche in Google Scholar
  • 3 Baek ST, Gibbs EM, Gleeson JG, Mathern GW. Hemimegalencephaly, a paradigm for somatic postzygotic neurodevelopmental disorders. Curr Opin Neurol 2013; 26 (02) 122-127
    CrossrefPubMedSuche in Google Scholar
  • 4 Sidira C, Vargiami E, Dragoumi P, Zafeiriou DI. Hemimegalencephaly and tuberous sclerosis complex: a rare yet challenging association. Eur J Paediatr Neurol 2021; 30: 58-65
    CrossrefPubMedSuche in Google Scholar
  • 5 Serletis D, MacDonald C, Xu Q. et al. Hemispherectomy for hemimegalencephaly in a 6.5-week-old infant with tuberous sclerosis complex. Childs Nerv Syst 2022; 38 (07) 1415-1419
    CrossrefPubMedSuche in Google Scholar
  • 6 Cuddapah VA, Thompson M, Blount J, Li R, Guleria S, Goyal M. Hemispherectomy for hemimegalencephaly due to tuberous sclerosis and a review of the literature. Pediatr Neurol 2015; 53 (05) 452-455
    CrossrefPubMedSuche in Google Scholar
  • 7 Guerra MP, Cavalleri F, Migone N. et al. Intractable epilepsy in hemimegalencephaly and tuberous sclerosis complex. J Child Neurol 2007; 22 (01) 80-84
    CrossrefPubMedSuche in Google Scholar
  • 8 Tinkle BT, Schorry EK, Franz DN, Crone KR, Saal HM. Epidemiology of hemimegalencephaly: a case series and review. Am J Med Genet A 2005; 139 (03) 204-211
    CrossrefPubMedSuche in Google Scholar
  • 9 Davis PE, Filip-Dhima R, Sideridis G. et al; Tuberous Sclerosis Complex Autism Center of Excellence Research Network. Presentation and diagnosis of tuberous sclerosis complex in infants. Pediatrics 2017; 140 (06) e20164040
    CrossrefPubMedSuche in Google Scholar
  • 10 Arnaez J, Sanchez-Acosta CG, Fasce J, Garcia-Alix A. Usefulness of two-channel amplitude-integrated EEG recording in a neonatal setting. J Matern Fetal Neonatal Med 2021; 34 (14) 2248-2258
    CrossrefPubMedSuche in Google Scholar
  • 11 Hellström-Westas L, De Vries LS, Rosén I. (eds) An atlas of amplitude-integrated EEGs in the newborn. 1st ed.. Parthenon Publishing Group; 2003
    Suche in Google Scholar
  • 12 Hellström-Westas L, De Vries LS, Rosén I. (eds) An atlas of amplitude-integrated EEGs in the newborn. 2nd ed.. Informa Healthcare; 2008
    CrossrefSuche in Google Scholar
  • 13 Hellström-Westas L, Svenningsen NW, Westgren U, Rosén I, Lagerström PO. Lidocaine for treatment of severe seizures in newborn infants. II. Blood concentrations of lidocaine and metabolites during intravenous infusion. Acta Paediatr 1992; 81 (01) 35-39
    CrossrefPubMedSuche in Google Scholar
  • 14 Sadowski K, Kotulska-Jóźwiak K, Jóźwiak S. Role of mTOR inhibitors in epilepsy treatment. Pharmacol Rep 2015; 67 (03) 636-646
    CrossrefPubMedSuche in Google Scholar
  • 15 Xu Q, Uliel-Sibony S, Dunham C. et al. mTOR inhibitors as a new therapeutic strategy in treatment resistant epilepsy in hemimegalencephaly: a case report. J Child Neurol 2019; 34 (03) 132-138
    CrossrefPubMedSuche in Google Scholar